Semax and Selank: The Two Most Studied Nootropic Peptides in Neuroscience
Semax and Selank are the two most widely researched nootropic peptides in neuroscience. Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Both have been studied for decades across hundreds of published papers. And both target the neurochemical systems that govern how clearly you think, how well you remember, and how effectively you manage stress — yet they do it through completely different mechanisms.
If you’ve encountered these peptides in research communities and wanted to understand the actual science, this article breaks down what Semax and Selank are, how they work, where the research stands, and why investigators often study them together.
What Is Semax? The Cognitive Amplifier
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It’s derived from the ACTH(4-10) fragment — a segment of adrenocorticotropic hormone that carries central nervous system activity. The C-terminal Pro-Gly-Pro tripeptide was added to improve metabolic stability and extend its biological half-life. Importantly, research has shown that this PGP tail carries independent pharmacological activity of its own — it activates neurotrophin transcription in brain tissue, making it an active contributor to Semax’s effects rather than a passive stabilizer.
Semax was first registered as a pharmaceutical in Russia in 1996. It has been studied in that country for over three decades, primarily through intranasal administration.
How Semax Works in the Brain
The primary mechanism that draws researchers to Semax is its effect on brain-derived neurotrophic factor (BDNF). BDNF is one of the most critical molecules in cognitive neuroscience — it supports neuron survival, drives the growth of new synapses, and underlies the brain’s ability to adapt and learn.
In a landmark study published in Brain Research, a single intranasal dose of Semax at 50 μg/kg in rodents produced remarkable hippocampal effects: a 1.4-fold increase in BDNF protein levels, a 3-fold increase in exon III BDNF mRNA, a 2-fold increase in trkB mRNA, and a 1.6-fold increase in trkB tyrosine phosphorylation. One dose. Hours. That’s not a marginal signal — that’s a robust neurotrophic response.
Beyond BDNF, Semax modulates multiple neurotransmitter systems simultaneously:
- Dopamine — associated with motivation, reward processing, and executive function
- Serotonin — linked to mood regulation, emotional stability, and impulse control
- Norepinephrine — involved in alertness, attention, and arousal
- Enkephalin system — Semax inhibits enkephalinase enzymes, preserving endogenous neuropeptides involved in pain modulation and stress response
Additionally, Semax interacts with melanocortin receptors — a receptor family involved in neuroprotection, inflammation, and energy homeostasis. Genome-wide transcriptional analysis has revealed that Semax enhances expression of genes related to immune function and neurotransmission, suggesting a scope of activity that goes well beyond simple cognitive enhancement.
What Semax Research Shows
In preclinical models, researchers have consistently observed:
- Enhanced learning acquisition and memory consolidation
- Improved information processing speed and attention
- Neuroprotective effects against oxidative stress and ischemic damage
- Upregulation of BDNF and nerve growth factor (NGF)
- Modulation of inflammatory gene expression in brain tissue
- Support for functional recovery in spinal cord injury models (2025 British Journal of Pharmacology)
A 2025 study published in the British Journal of Pharmacology demonstrated that Semax targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury — extending its research applications well beyond cognition into neuroprotection and neurorecovery.
It is important to note that the majority of published Semax research comes from preclinical models. While Semax has been used clinically in Russia for decades, controlled clinical trials meeting Western regulatory standards remain limited. All claims in this article refer to preclinical and laboratory findings.
What Is Selank? The Calm Without the Cost
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed as a metabolically stable analog of tuftsin — a naturally occurring tetrapeptide found in the heavy chain of human immunoglobulin G that plays a role in immune regulation. Like Semax, Selank incorporates the Pro-Gly-Pro tripeptide at its C-terminus to improve stability and extend its duration of action.
Where Semax amplifies cognitive throughput, Selank’s primary research profile centers on anxiolytic and mood-stabilizing effects — achieved without the sedation, cognitive impairment, or dependence risks associated with benzodiazepine drugs.
How Selank Works in the Brain
Selank’s anxiolytic mechanism operates primarily through the GABAergic system. GABA (gamma-aminobutyric acid) is the brain’s primary inhibitory neurotransmitter — it reduces neuronal excitability and produces states of calm. Benzodiazepines like diazepam work by enhancing GABA-A receptor function. Selank appears to modulate the same system through a different pathway.
Research published in Frontiers in Molecular Neuroscience examined the expression of 84 genes linked to neurotransmission following exposure to Selank or GABA. The results showed a positive correlation between gene expression patterns, suggesting that Selank modulates the GABAergic system through transcriptional regulation rather than direct receptor binding alone. This mechanism may explain why Selank produces sustained anxiolytic effects without the tolerance, withdrawal, or cognitive dulling associated with benzodiazepines.
Beyond GABA modulation, Selank influences multiple neurochemical pathways:
- Serotonin metabolism — Selank affects serotonin turnover and receptor dynamics, contributing to mood stability
- BDNF expression — like Semax, Selank rapidly elevates hippocampal BDNF, supporting neuroplasticity
- Interleukin-6 (IL-6) signaling — Selank modulates inflammatory cytokine balance through its tuftsin-derived immunomodulatory properties
- T helper cell balance — research has demonstrated effects on immune cell differentiation, linking Selank’s anxiolytic and immunomodulatory profiles
- Enkephalin preservation — Selank inhibits enkephalin degradation enzymes, supporting endogenous stress-buffering neuropeptide activity
What Selank Research Shows
In preclinical and limited clinical models, researchers have documented:
- Anxiolytic effects comparable to low-dose benzodiazepines without sedation or dependence
- Enhanced memory retention and learning under conditions of stress
- Increased GABA-A receptor density in the hippocampus
- Modulation of serotonergic and dopaminergic neurotransmitter dynamics
- Immunomodulatory effects including cytokine regulation and antiviral activity
- Rapid elevation of BDNF expression in hippocampal tissue
- Enhancement of diazepam’s anxiolytic effects when combined in stress models (PubMed Central)
Clinical trials conducted in Russia demonstrated that Selank’s anxiolytic potency was comparable to conventional benzodiazepines in patients with generalized anxiety disorder and neurasthenia — but without the characteristic side effect profile of those drugs.
Semax vs Selank: How They Compare
Understanding the distinction between these two peptides is essential for researchers designing cognitive and neuropsychiatric protocols.
Semax: The Accelerator
Semax primarily amplifies cognitive signal. It increases BDNF, drives dopamine and serotonin activity, enhances attention and memory processing, and provides neuroprotective coverage. In research terms, Semax is studied for what it adds to cognitive performance — more neurotrophic support, more neurotransmitter availability, more processing capacity.
Selank: The Stabilizer
Selank primarily reduces cognitive noise. It modulates GABA to lower anxiety, stabilizes serotonin metabolism to smooth mood fluctuations, and dampens inflammatory signaling that disrupts neural function. In research terms, Selank is studied for what it removes — the anxiety, the neuroinflammation, the stress-driven interference that prevents clear thinking.
The Complementary Logic
This is why researchers frequently study Semax and Selank together. One amplifies signal. The other reduces noise. The combination addresses both sides of cognitive performance — and the published literature on their individual mechanisms suggests they operate through sufficiently different pathways to be genuinely complementary rather than redundant.
Some research protocols explore sequential or concurrent administration. Because Semax primarily engages melanocortin receptors, BDNF/TrkB signaling, and monoamine neurotransmitter systems, while Selank primarily engages GABAergic modulation, immune signaling, and enkephalin preservation, the mechanistic overlap is minimal. This makes the combination particularly attractive for investigators studying multi-target approaches to cognitive and emotional regulation.
The PGP Connection: A Shared Structural Feature
Both Semax and Selank share the C-terminal Pro-Gly-Pro (PGP) tripeptide. This is not a coincidence — PGP has demonstrated independent biological activity in research. Studies have shown that PGP alone activates neurotrophin transcription and carries anti-inflammatory properties. The shared PGP motif contributes to both peptides’ metabolic stability and may partially explain their overlapping neuroprotective effects despite targeting different primary receptor systems.
This structural relationship also makes Semax and Selank relevant to broader research into proline-rich peptide biology and the design of metabolically stable neuropeptide analogs.
Practical Research Considerations
For laboratory investigators working with Semax and Selank, several practical factors are worth noting:
- Administration route — the majority of published research uses intranasal administration, taking advantage of direct nose-to-brain delivery via the olfactory and trigeminal pathways
- Dosing protocols — Semax research typically uses 50-600 μg/kg ranges in rodent models; Selank research uses similar microgram-per-kilogram dosing
- Stability — both peptides should be stored lyophilized at -20°C and reconstituted immediately before use; the PGP motif improves but does not eliminate enzymatic degradation
- Clearance — Selank is rapidly metabolized and cleared from circulation within approximately 10 minutes of administration, though downstream gene expression changes persist much longer
- Species considerations — the majority of published data comes from rodent models; human pharmacokinetic data remains limited in Western literature
The Broader Nootropic Peptide Landscape
Semax and Selank sit within a growing field of peptides studied for cognitive and neuropsychiatric applications. For researchers exploring complementary or adjacent mechanisms, several compounds in the Dobry Peptides catalog engage overlapping pathways:
NAD+ 500MG — essential coenzyme for mitochondrial energy production and sirtuin activation, both foundational to sustained cognitive performance and neuronal health
Epitalon 10MG — synthetic tetrapeptide studied for pineal gland function and circadian rhythm regulation, directly influencing sleep quality and cognitive recovery
VIP 10MG — vasoactive intestinal peptide with neuroprotective, anti-inflammatory, and circadian-regulating properties relevant to cognitive resilience research
DSIP 10MG — delta sleep-inducing peptide studied for sleep architecture modulation, with implications for cognitive recovery and neuroendocrine regulation during rest
KPV 10MG — alpha-MSH fragment with anti-inflammatory activity via NF-kB modulation, relevant to neuroinflammation research intersecting with cognitive function
Looking for Semax, Selank, or Something Specific?
Dobry Peptides is continuously expanding our research catalog based on demand from the scientific community. If you’re looking for Semax, Selank, or any compound not currently listed on our website, reach out directly at support@dobrypeptides.com and we’ll work to accommodate your research needs.
We’re a small operation by design — which means direct communication, personal attention, and the flexibility to source compounds that larger vendors can’t or won’t.
All products sold by Dobry Peptides are intended strictly for research and development purposes. They are not for human or animal consumption. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
Dobry Peptides — Stronger living through science.
Browse our full catalog | Contact us | support@dobrypeptides.com